Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global Market – Forecast To 2024
| Publishing Date : | May, 2018 |
| Report Code : | HCMD0160 |
| Price: |
Single license $4,950
Site license $6,750 Global license $9,000 |
Note: The report would be dispatched after confirmation of payment
The Cardiac electrophysiology mapping, navigation and recording devices are used to assess the timing and propagation of cardiac electrical activity, which are obtained using multiple intravascular electrode catheters positioned at various locations within the heart. According to IQ4I analysis, the cardiac electrophysiology mapping, navigation and recording devices global market is expected to grow at mid single digit CAGR to reach $1,447.3 million by 2024. The cardiac EP mapping, navigation and recording devices market is mainly segmented by products, end-users and by geography. Cardiac EP mapping, navigation and recording devices by products is segmented into mapping and navigation systems, mapping catheters and navigation catheters, recording systems and accessories. Among the products, recording systems hold the highest share in 2017 and expected to grow at low single digit CAGR to reach $519.5 million by 2024. Mapping and Navigation Catheters segment is expected to grow at a high CAGR from 2017 to 2024. The mapping systems and navigation systems segment is further segmented by mapping system type as contact mapping systems and non contact mapping systems. The contact mapping segment holds the highest share of 70.5% in 2017 and expected to grow at mid single digit CAGR from 2017 to 2024.
End-Users of Cardiac EP mapping, navigation and recording devices are segmented into hospitals, cardiac & ambulatory surgical centres and academics & research institutes. The hospital segment commanded the largest revenue in 2017 and expected to grow at mid CAGR during the forecasting period. Cardiac & ambulatory surgical centres segment is expected to grow at a strong CAGR from 2017 to 2024.
The Cardiac EP mapping, navigation and recording devices global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North American region commanded the largest revenue in 2017 and Asia-Pacific is expected to grow at highest CAGR during the forecasting period.
Some of the major players in Cardiac EP mapping, navigation and recording devices market include Abbott Laboratories (St Jude Medical) (U.S.), Boston Scientific (U.S.), Johnson & Johnson (Biosense Webster) (U.S.), Medtronic PLC. (Ireland), Stereotaxis, Inc. (U.S.), Acutus Medical (U.S.), GE Healthcare (U.S.), Auris Surgical Robotics (Hansen Medical), Microport Scientific Corporation (China), Magnetecs Corporation (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Others
• Europe
o Germany
o U.K.
o France
o Others
• Asia-Pacific
o Japan
o China
o India
o Others
• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o Middle East & Others
- 1 EXECUTIVE SUMMARY
- 2 INTRODUCTION
- 2.1 KEY TAKEAWAYS
- 2.2 SCOPE OF THE REPORT
- 2.3 REPORT DESCRIPTION
- 2.4 MARKETS COVERED
- 2.5 STAKEHOLDERS
- 2.6 RESEARCH METHODOLOGY
- 2.6.1 MARKET SIZE ESTIMATION
- 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
- 2.6.3 SECONDARY SOURCES
- 2.6.4 PRIMARY SOURCES
- 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
- 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
- 2.6.7 ASSUMPTIONS
- 3 MARKET ANALYSIS
- 3.1 INTRODUCTION
- 3.2 MARKET SEGMENTATION
- 3.3 FACTORS INFLUENCING MARKET
- 3.3.1 DRIVERS AND OPPORTUNITIES
- 3.3.1.1 INCREASE IN NUMBER OF PATIENTS WITH ARRHYTHMIA
- 3.3.1.2 EMERGING TECHNOLOGIES IN ELECTROPHYSIOLOGY
- 3.3.1.3 RISING GERIATRIC POPULATION PRONE TO CHRONIC DISORDERS
- 3.3.1.4 INCREASE IN RESEARCH AND DEVELOPMENT ACTIVITIES
- 3.3.1.5 INCREASE IN MINIMALLY INVASIVE SURGERY FOR ATRIAL FIBRILLATION
- 3.3.2 RESTRAINTS AND THREATS
- 3.3.2.1 HIGH COST OF THE DEVICES
- 3.3.2.2 EXPOSURE TO RADIATION
- 3.3.2.3 INACCURACY OF THE IMAGING SYSTEMS DUE TO BODY MOVEMENTS
- 3.3.2.4 STRINGENT REGULATORY GUIDELINES
- 3.3.2.5 LACK OF SKILLED AND TRAINED PROFESSIONALS
- 3.3.2.6 AVAILABILITY OF ALTERNATIVE PRODUCTS
- 3.4 REGULATORY AFFAIRS
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
- 3.4.1.1 ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
- 3.4.1.2 ISO 13485 MEDICAL DEVICES
- 3.4.1.3 ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
- 3.4.2 U.S.
- 3.4.3 CANADA
- 3.4.4 EUROPE
- 3.4.5 JAPAN
- 3.4.6 CHINA
- 3.4.7 INDIA
- 3.5 REIMBURSEMENT SCENARIO
- 3.5.1 REIMBURSEMENT TABLE
- 3.6 PATENT TRENDS
- 3.7 TECHNOLOGICAL ADVANCEMENTS
- 3.7.1 INTRODUCTION
- 3.7.2 RHYTHMIA HDX MAPPING SYSTEM
- 3.7.3 ENSITE PRESICION MAPPING SYSTEM
- 3.7.4 ACQMAP HIGH RESOLUTION IMAGING AND MAPPING SYSTEM
- 3.8 PORTER’S FIVE FORCE ANALYSIS
- 3.8.1 THREAT OF NEW ENTRANTS
- 3.8.2 THREAT OF SUBSTITUTES
- 3.8.3 BARGAINING POWER OF SUPPLIERS
- 3.8.4 BARGAINING POWER OF BUYERS
- 3.8.5 COMPETITIVE RIVALRY
- 3.9 SUPPLY CHAIN ANALYSIS
- 3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
- 3.10.1 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL
- 3.10.2 MARKET SHARE ANALYSIS OF MAPPING AND NAVIGATION SYSTEMS
- 3.10.3 MARKET SHARE ANALYSIS OF RECORDING SYSTEMS
- 3.11 MARKET PENETRATION OF CARDIAC EP MAPPING CATHETER AND NAVIGATION CATHETER PROCEDURES IN GLOBAL CARDIAC ABLATION PROCEDURES AND GLOBAL CARDIAC SURGERIES
- 3.12 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES NUMBER OF UNITS BY REGION
- 3.12.1 MAPPING SYSTEMS AND NAVIGATION SYSTEMS NUMBER OF UNITS BY REGION
- 3.12.2 RECORDING SYSTEMS NUMBER OF UNITS BY REGION
- 3.13 MAPPING CATHETERS AND NAVIGATION CATHETERS GLOBAL PROCEDURAL VOLUME, BY REGION
- 3.14 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES COMPANY COMPARISON TABLE, BY PRODUCTS
- 4 CARDIAC ELECTROPHYSIOLOGY (EP) MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET, BY PRODUCT
- 4.1 INTRODUCTION
- 4.2 MAPPING SYSTEMS AND NAVIGATION SYSTEMS
- 4.2.1 CONTACT MAPPING SYSTEMS
- 4.2.2 NON CONTACT MAPPING SYSTEMS
- 4.3 MAPPING CATHETERS AND NAVIGATION CATHETERS
- 4.4 RECORDING SYSTEMS
- 4.5 ACCESSORIES
- 5 CARDIAC ELECTROPHYSIOLOGY (EP) MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET, BY END-USERS
- 5.1 INTRODUCTION
- 5.2 HOSPITALS
- 5.3 CARDIAC CENTERS/AMBULATORY SURGICAL CENTERS
- 5.4 OTHER END-USER
- 6 REGIONAL ANALYSIS
- 6.1 INTRODUCTION
- 6.2 NORTH AMERICA
- 6.2.1 U.S.
- 6.2.2 OTHERS
- 6.3 EUROPE
- 6.3.1 GERMANY
- 6.3.2 U.K.
- 6.3.3 FRANCE
- 6.3.4 OTHERS
- 6.4 APAC
- 6.4.1 JAPAN
- 6.4.2 CHINA
- 6.4.3 INDIA
- 6.4.4 OTHERS
- 6.5 ROW
- 6.5.1 BRAZIL
- 6.5.2 REST OF LATAM
- 6.5.3 MIDDLE EAST & OTHERS
- 7 COMPETITIVE LANDSCAPE
- 7.1 INTRODUCTION
- 7.2 APPROVALS
- 7.3 NEW PRODUCT LAUNCH
- 7.4 ACQUISITIONS
- 7.5 AGREEMENTS
- 8 MAJOR COMPANIES
- 8.1 ABBOTT LABORATORIES
- 8.1.1 OVERVIEW
- 8.1.2 FINANCIALS
- 8.1.3 PRODUCT PORTFOLIO
- 8.1.4 KEY DEVELOPMENTS
- 8.1.5 BUSINESS STRATEGY
- 8.1.6 SWOT ANALYSIS
- 8.2 ACUTUS MEDICAL
- 8.2.1 OVERVIEW
- 8.2.2 FINANCIALS
- 8.2.3 PRODUCT PORTFOLIO
- 8.2.4 KEY DEVELOPMENTS
- 8.2.5 BUSINESS STRATEGY
- 8.2.6 SWOT ANALYSIS
- 8.3 AURIS SURGICAL ROBOTICS (HANSEN MEDICAL)
- 8.3.1 OVERVIEW
- 8.3.2 FINANCIALS
- 8.3.3 PRODUCT PORTFOLIO
- 8.3.4 KEY DEVELOPMENTS
- 8.3.5 BUSINESS STRATEGY
- 8.3.6 SWOT ANALYSIS
- 8.4 BOSTON SCIENTIFIC CORPOARTION
- 8.4.1 OVERVIEW
- 8.4.2 FINANCIALS
- 8.4.3 PRODUCT PORTFOLIO
- 8.4.4 KEY DEVELOPMENTS
- 8.4.5 BUSINESS STRATEGY
- 8.4.6 SWOT ANALYSIS
- 8.5 GE HEALTHCARE (GENERAL ELECTRIC COMPANY)
- 8.5.1 OVERVIEW
- 8.5.2 FINANCIALS
- 8.5.3 PRODUCT PORTFOLIO
- 8.5.4 KEY DEVELOPMENTS
- 8.5.5 BUSINESS STRATEGY
- 8.5.6 BUSINESS STRATEGY
- 8.6 JOHNSON & JOHNSON (BIOSENSE WEBSTER)
- 8.6.1 OVERVIEW
- 8.6.2 FINANCIALS
- 8.6.3 PRODUCT PORTFOLIO
- 8.6.4 KEY DEVELOPMENTS
- 8.6.5 BUSINESS STRATEGY
- 8.6.6 SWOT ANALYSIS
- 8.7 MAGNETECS CORPORTION
- 8.7.1 OVERVIEW
- 8.7.2 FINANCIALS
- 8.7.3 PRODUCT PORTFOLIO
- 8.7.4 KEY DEVELOPMENTS
- 8.7.5 BUSINESS STRATEGY
- 8.7.6 SWOT ANALYSIS
- 8.8 MEDTRONIC, PLC
- 8.8.1 OVERVIEW
- 8.8.2 FINANCIALS
- 8.8.3 PRODUCT PORTFOLIO
- 8.8.4 KEY DEVELOPMENTS
- 8.8.5 BUSINESS STRATEGY
- 8.8.6 SWOT ANALYSIS
- 8.9 MICROPORT SCEINTIFIC CORPORTION
- 8.9.1 OVERVIEW
- 8.9.2 FINANCIALS
- 8.9.3 PRODUCT PORTFOLIO
- 8.9.4 KEY DEVELOPMENTS
- 8.9.5 BUSINESS STRATEGY
- 8.9.6 SWOT ANALYSIS
- 8.10 STEREOTAXIS, INC.
- 8.10.1 OVERVIEW
- 8.10.2 FINANCIALS
- 8.10.3 PRODUCT PORTFOLIO
- 8.10.4 KEY DEVELOPMENTS
- 8.10.5 BUSINESS STRATEGY
- 8.10.6 SWOT ANALYSIS
- TABLE 1 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 2 MAPPING SYSTEMS AND NAVIGATION SYSTEMS NUMBER OF UNITS, BY REGION (2016-2024) (NO’S)
- TABLE 3 RECORDING SYSTEMS NUMBER OF UNITS, BY REGION (2016-2024) (NO’S)
- TABLE 4 MAPPING CATHETERS AND NAVIGATION CATHETERS GLOBAL PROCEDURAL VOLUME, BY REGION (2016-2024) (NO’S)
- TABLE 5 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 6 MAPPING SYSTEMS AND NAVIGATION SYSTEMS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
- TABLE 7 MAPPING SYSTEMS AND NAVIGATION SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 8 CONTACT MAPPING SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 9 NON CONTACT MAPPING SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 10 MAPPING CATHETERS AND NAVIGATION CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 11 RECORDING SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 12 ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 13 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
- TABLE 14 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 15 CARDIAC CENTERS/AMBULATORY SURGERY CENTERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 16 OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 17 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 18 NORTH AMERICA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 19 NORTH AMERICA MAPPING SYSTEMS AND NAVIGATION SYSTEMS MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
- TABLE 20 NORTH AMERICA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
- TABLE 21 NORTH AMERICA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
- TABLE 22 EUROPE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 23 EUROPE MAPPING SYSTEMS AND NAVIGATION SYSTEMS MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
- TABLE 24 EUROPE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
- TABLE 25 EUROPE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
- TABLE 26 APAC CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 27 APAC MAPPING SYSTEMS AND NAVIGATION SYSTEMS MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
- TABLE 28 APAC CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
- TABLE 29 APAC CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
- TABLE 30 ROW CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 31 ROW MAPPING SYSTEMS AND NAVIGATION SYSTEMS MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
- TABLE 32 ROW CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
- TABLE 33 ROW CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
- TABLE 34 APPROVALS (2016 - 2018)
- TABLE 35 NEW PRODUCT LAUNCH (2016 - 2018)
- TABLE 36 ACQUISITIONS (2016 - 2018)
- TABLE 37 AGREEMENTS (2016 - 2018)
- TABLE 38 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 39 ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2015-2017) ($MN)
- TABLE 40 ABBOTT LABORATORIES: CARDIOVASCULAR AND NEUROMODULATION SEGMENTS REVENUE (2015-2017) ($MN)
- TABLE 41 ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 42 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 43 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2015-2017) ($MN)
- TABLE 44 BOSTON SCIENTIFIC CORPORATION:RHYTHM MANAGEMENT, BY SEGMNETS, (2015-2017) ($MN)
- TABLE 45 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 46 GE HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 47 GE HEALTHCARE: TOTAL REVENUE, BY SEGMENTS (2015-2017) ($MN)
- TABLE 48 GE HEALTHCARE: REVENUE, BY HEALTH CARE SUB- SEGMENTS (2015-2017) ($MN)
- TABLE 49 GE HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
- TABLE 50 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 51 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
- TABLE 52 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 53 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 54 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
- TABLE 55 MEDTRONIC, PLC: CARDIAC & VASCULAR TOTAL REVENUE, BY SUB-SEGMENTS, (2015-2017) ($MN)
- TABLE 56 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 57 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 58 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2015-2017) ($MN)
- TABLE 59 MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 60 STEREOTAXIS, INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 61 STEREOTAXIS, INC.: TOTAL REVENUE BY SEGMENTS, (2015-2017) ($MN)
- TABLE 62 STEREOTAXIS, INC.: TOTAL REVENUE BY GEOGRAPHY, (2015-2017) ($MN)
- FIGURE 1 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
- FIGURE 2 RESEARCH METHODOLOGY: CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET
- FIGURE 3 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
- FIGURE 4 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET: FORECASTING MODEL
- FIGURE 5 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
- FIGURE 6 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET SEGMENTATION
- FIGURE 7 MARKET DYNAMICS
- FIGURE 8 CARDIAC ELECTROPHYSIOLOGY MAPPING AND RECORDING DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2013–2017)
- FIGURE 9 CARDIAC ELECTROPHYSIOLOGY NAVIGATION DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2013–2017)
- FIGURE 10 CARDIAC ELECTROPHYSIOLOGY MAPPING, NAVIGATION AND RECORDING DEVICE GLOBAL MARKET: PORTER’S ANALYSIS
- FIGURE 11 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 12 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
- FIGURE 13 CARDIAC ELECTROPHYSIOLOGY MAPPING AND NAVIGATION SYSTEMS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
- FIGURE 14 CARDIAC ELECTROPHYSIOLOGY RECORDING SYSTEMS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
- FIGURE 15 CARDIAC EP MAPPING CATHETER AND NAVIGATION CATHETER PROCEDURES GLOBAL MARKET PENETRATION, (2017) (NO’S)
- FIGURE 16 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY PRODUCT (2017 V/S 2024) (%)
- FIGURE 17 MAPPING SYSTEMS AND NAVIGATION SYSTEMS GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2017) ($MN)
- FIGURE 18 MAPPING SYSTEMS AND NAVIGATION SYSTEMS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 19 CONTACT MAPPING SYSTEMS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 20 NON CONTACT MAPPING SYSTEMS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 21 MAPPING CATHETERS AND NAVIGATION CATHETERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 22 RECORDING SYSTEMS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 23 ACCESSORIES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 24 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2017 V/S 2024) (%)
- FIGURE 25 HOSPITALS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 26 CARDIAC CENTERS/AMBULATORY SURGERY CENTERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 27 OTHER END-USERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 28 CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN), CAGR (%)
- FIGURE 29 NORTH AMERICA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) (%)
- FIGURE 30 NORTH AMERICA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES REVENUE, BY COUNTRY (2017 V/S 2024) (%)
- FIGURE 31 U.S. CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 32 OTHER NORTH AMERICA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 33 EUROPE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) (%)
- FIGURE 34 EUROPE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES REVENUE, BY COUNTRY (2017 V/S 2024) (%)
- FIGURE 35 GERMANY CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 36 U.K. CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 37 FRANCE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 38 OTHER EUROPE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 39 APAC CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) (%)
- FIGURE 40 APAC CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES REVENUE, BY COUNTRY (2017 V/S 2024) (%)
- FIGURE 41 JAPAN CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 42 CHINA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 43 INDIA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 44 OTHER APAC CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 45 ROW CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) (%)
- FIGURE 46 ROW CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES REVENUE, BY COUNTRY (2017 V/S 2024) (%)
- FIGURE 47 BRAZIL CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 48 REST OF LATAM CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 49 MIDDLE EAST & OTHERS CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
- FIGURE 50 KEY GROWTH STRATEGIES, (2016-2018)
- FIGURE 51 SWOT: ABBOTT LABORATORIES
- FIGURE 52 SWOT: ACUTUS MEDICAL
- FIGURE 53 SWOT: AURIS SURGICAL ROBOTICS (HANSEN MEDICAL)
- FIGURE 54 SWOT: BOSTON SCIENTIFIC CORPORATION
- FIGURE 55 SWOT: GE HEALTHCARE
- FIGURE 56 SWOT: BIOSENSE WEBSTER
- FIGURE 57 SWOT: MAGNETECS CORPORATION
- FIGURE 58 SWOT: MEDTRONIC, PLC
- FIGURE 59 SWOT: MICROPORT SCIENTIFIC CORPORATION (HANSEN MEDICAL)
- FIGURE 60 SWOT: STEREOTAXIS, INC.